What is Zacks Research’s Forecast for Zoetis Q2 Earnings?

Zoetis Inc. (NYSE:ZTS) – Investment analysts at Zacks Research cut their Q2 2025 earnings per share (EPS) estimates for Zoetis in a report issued on Tuesday, December 3rd. Zacks Research analyst E. Bagri now forecasts that the company will post earnings per share of $1.65 for the quarter, down from their prior forecast of $1.66. The consensus estimate for Zoetis’ current full-year earnings is $5.90 per share. Zacks Research also issued estimates for Zoetis’ Q3 2025 earnings at $1.66 EPS and Q3 2026 earnings at $1.78 EPS.

A number of other research firms have also recently issued reports on ZTS. Stifel Nicolaus lifted their target price on shares of Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a research note on Wednesday, September 18th. Leerink Partners initiated coverage on shares of Zoetis in a research note on Monday. They issued an “outperform” rating and a $215.00 target price for the company. JPMorgan Chase & Co. lifted their target price on shares of Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Argus upgraded shares of Zoetis to a “strong-buy” rating in a research note on Friday, August 9th. Finally, Piper Sandler lifted their target price on shares of Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a research note on Wednesday, August 14th. Eleven analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $220.80.

Zoetis Stock Down 0.3 %

NYSE ZTS opened at $174.77 on Thursday. The company has a current ratio of 3.69, a quick ratio of 2.27 and a debt-to-equity ratio of 1.26. The stock’s 50 day moving average is $182.43 and its two-hundred day moving average is $180.93. The company has a market capitalization of $78.85 billion, a price-to-earnings ratio of 32.85, a PEG ratio of 2.89 and a beta of 0.89. Zoetis has a 1-year low of $144.80 and a 1-year high of $201.92.

Zoetis (NYSE:ZTS) last released its earnings results on Monday, November 4th. The company reported $1.58 earnings per share for the quarter, topping analysts’ consensus estimates of $1.46 by $0.12. The business had revenue of $2.40 billion for the quarter, compared to the consensus estimate of $2.29 billion. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. The firm’s revenue for the quarter was up 11.6% compared to the same quarter last year. During the same period last year, the business earned $1.36 earnings per share.

Institutional Trading of Zoetis

A number of institutional investors have recently bought and sold shares of the business. Asset Dedication LLC grew its holdings in Zoetis by 4.8% during the 2nd quarter. Asset Dedication LLC now owns 1,174 shares of the company’s stock worth $204,000 after acquiring an additional 54 shares during the period. Forza Wealth Management LLC grew its holdings in shares of Zoetis by 1.8% in the 2nd quarter. Forza Wealth Management LLC now owns 3,313 shares of the company’s stock valued at $574,000 after buying an additional 58 shares during the period. Cherry Creek Investment Advisors Inc. grew its holdings in shares of Zoetis by 2.0% in the 3rd quarter. Cherry Creek Investment Advisors Inc. now owns 3,021 shares of the company’s stock valued at $590,000 after buying an additional 58 shares during the period. L. Roy Papp & Associates LLP grew its holdings in shares of Zoetis by 2.8% in the 2nd quarter. L. Roy Papp & Associates LLP now owns 2,221 shares of the company’s stock valued at $385,000 after buying an additional 60 shares during the period. Finally, Grove Bank & Trust grew its holdings in shares of Zoetis by 0.5% in the 3rd quarter. Grove Bank & Trust now owns 11,763 shares of the company’s stock valued at $2,298,000 after buying an additional 61 shares during the period. Institutional investors and hedge funds own 92.80% of the company’s stock.

Zoetis Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 3rd. Investors of record on Thursday, October 31st were given a $0.432 dividend. This represents a $1.73 annualized dividend and a yield of 0.99%. The ex-dividend date was Thursday, October 31st. Zoetis’s dividend payout ratio (DPR) is presently 32.52%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.